99 related articles for article (PubMed ID: 30114953)
1. Combination therapy of hepatocellular carcinoma by DNA shuffling-based VEGF vaccine and doxorubicin.
Li Z; Ding J; Zhao X; Qi G
Immunotherapy; 2018 Aug; 10(11):951-969. PubMed ID: 30114953
[TBL] [Abstract][Full Text] [Related]
2. Constructing Tumor Vaccines Targeting for Vascular Endothelial Growth Factor (VEGF) by DNA Shuffling.
Bie N; Zhao X; Li Z; Qi G
J Immunother; 2016 Sep; 39(7):260-8. PubMed ID: 27428264
[TBL] [Abstract][Full Text] [Related]
3. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
[TBL] [Abstract][Full Text] [Related]
4. Two tandem repeats of mHSP70
Xu M; Zhang Y; Dong W; Jiang L; Zhang J; Yu P; Xie S; Zhou L
Life Sci; 2018 May; 201():102-110. PubMed ID: 29572180
[TBL] [Abstract][Full Text] [Related]
5. [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice].
Liu FJ; Tan G; Li J; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2147-51. PubMed ID: 19080480
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
7. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
[TBL] [Abstract][Full Text] [Related]
8. Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model.
Jin D; Yu X; Chen B; Li Z; Ding J; Zhao X; Qi G
Immunotherapy; 2017 Jun; 9(7):537-553. PubMed ID: 28509606
[TBL] [Abstract][Full Text] [Related]
9. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of DNA vaccine potency against legumain.
Smahel M; Duskova M; Polakova I; Musil J
J Immunother; 2014 Jun; 37(5):293-303. PubMed ID: 24810641
[TBL] [Abstract][Full Text] [Related]
11. HER-2 DNA and protein vaccines containing potent Th cell epitopes induce distinct protective and therapeutic antitumor responses in HER-2 transgenic mice.
Renard V; Sonderbye L; Ebbehøj K; Rasmussen PB; Gregorius K; Gottschalk T; Mouritsen S; Gautam A; Leach DR
J Immunol; 2003 Aug; 171(3):1588-95. PubMed ID: 12874253
[TBL] [Abstract][Full Text] [Related]
12. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models.
Xu A; Zhang L; Chen Y; Lin Z; Li R
Cancer Immunol Immunother; 2017 Feb; 66(2):181-192. PubMed ID: 27872951
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
Zou Y; Guo CG; Zhang MM
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
[TBL] [Abstract][Full Text] [Related]
15. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.
Rad FH; Le Buanec H; Paturance S; Larcier P; Genne P; Ryffel B; Bensussan A; Bizzini B; Gallo RC; Zagury D; Uzan G
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2837-42. PubMed ID: 17301234
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of endostatin enhances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice.
Liu F; Tan G; Li J; Dong X; Krissansen GW; Sun X
Cancer Sci; 2007 Sep; 98(9):1381-7. PubMed ID: 17627616
[TBL] [Abstract][Full Text] [Related]
17. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine.
Xu M; Zhou L; Zhang P; Lu Y; Ge C; Yao W; Xing Y; Xiao W; Dong Y; Wu J; Cao R; Li T
Tumour Biol; 2013 Oct; 34(5):3173-82. PubMed ID: 23771850
[TBL] [Abstract][Full Text] [Related]
19. Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.
Chen Y; Yang D; Li S; Gao Y; Jiang R; Deng L; Frankel FR; Sun B
Oncogene; 2012 Apr; 31(17):2140-52. PubMed ID: 21927025
[TBL] [Abstract][Full Text] [Related]
20. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
